AARDVARK THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
Aardvark Therapeutics Strengthens Board with Industry Leaders
Aardvark Therapeutics, Inc. has appointed Dr. Roy D. Baynes and Susan E. Graf to its Board of Directors, aiming to bolster its leadership and advance its innovative therapies for metabolic diseases. The company is progressing with its lead product candidate, ARD-101, through Phase 3 development for Prader-Willi Syndrome and planning a Phase 2 trial for hypothalamic obesity.
© Copyright 2025. All Rights Reserved by MedPath